New drug delivery system developed with the help of curcumin, the main ingredient in the turmeric spice can prevent bone cancer cells from spreading and promotes the growth of healthy bone cells.
Curcumin, the active constituent of the turmeric spice can successfully inhibit bone cancer cells while promoting the growth of healthy bone cells, reveals a new study. The findings of the study are published in the journal ACS Applied Materials and Interfaces. The work could lead to better post-operative treatments for people with osteosarcoma, the second most prevalent cause of cancer death in children.
‘Turmeric which has been used in cooking and as medicine for centuries in Asian countries has anti-oxidant, anti-inflammatory and bone-building capabilities due to its active ingredient, curcumin.’
Read More..
The researchers, including Susmita Bose, Herman and Brita Lindholm Endowed Chair Professor in the School of Mechanical and Materials Engineering, and graduate student Naboneeta Sarkar, report on their work in the journal.Read More..
Young patients with bone cancer are often treated with high doses of chemotherapy before and after surgery, many of which have harmful side effects. Researchers would like to develop gentler treatment options, especially after surgery when patients are trying to recover from bone damage at the same time that they are taking harsh drugs to suppress tumor growth.
Turmeric has been used in cooking and as medicine for centuries in Asian countries, and its active ingredient, curcumin has been shown to have anti-oxidant, anti-inflammatory and bone-building capabilities. It has also been shown to prevent various forms of cancers.
"I want people to know the beneficial effects of these natural compounds," said Bose. "Natural biomolecules derived from these plant-based products are inexpensive and a safer alternative to synthetic drugs."
However, when taken orally as medicine, the compound can't be absorbed well in the body. It is metabolized and eliminated too quickly.
Advertisement
The researchers found that their system inhibited the growth of osteosarcoma cells by 96 percent after 11 days as compared to untreated samples. The system also promoted healthy bone cell growth.
Advertisement
Source-Eurekalert